Dipyridamole-associated pulmonary edema: discovery of a new potential adverse reaction signal based on the FAERS database
These findings underscore the need for tailored safety monitoring strategies and more nuanced risk-benefit assessments in the clinical use of dipyridamole.
Authors
- PEIGUANG NIU
- X. Zeng (ORCID: https://orcid.org/0000-0002-1911-9162)
- Jintuo Zhou
- Tingting Chen (ORCID: https://orcid.org/0000-0002-3918-5132)
- Xiaomin Dong
- Guimu Guo (ORCID: https://orcid.org/0000-0002-3573-7446)
- Jinhua Zhang
- Ruoxuan Pan
Institutions
- Fujian Medical University (CN)
- Guilin Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1080/14740338.2026.2618005
- Primary Topic
- Cardiac electrophysiology and arrhythmias
- Type
- article
- Field-Weighted Citation Impact
- 0.00